Heritability of the spatial distribution and peak density of macular pigment: A classical twin study

Eye (Basingstoke)

Volumn 26, Issue 9, 2012, Pages 1217-1225

  Hogg, R E ^a,b   Ong, E L ^b,c   Chamberlain, M ^b   Dirani, M ^b   Baird, P N ^b   Guymer, R H ^b   Fitzke, F ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Heritability; Lutein; Macular pigment; Twin study; Zeaxanthin

Indexed keywords

VISUAL PIGMENT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CORRELATION ANALYSIS; DIZYGOTIC TWINS; FEMALE; HERITABILITY; HUMAN; MALE; MONOZYGOTIC TWINS; OUTCOME ASSESSMENT; RELATIVE PEAK DENSITY; RELATIVE SPATIAL DISTRIBUTION; RETINA MACULA AGE RELATED DEGENERATION; VISUAL SYSTEM PARAMETERS;

EID: 84867568866     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.98     Document Type: Article

References (54)

1. Khachik F, Englert G, Daitch CE, Beecher GR, Tonucci LH, Lusby WR. Isolation and structural elucidation of the geometrical isomers of lutein and zeaxanthin in extracts from human plasma. J Chromatogr 1992; 582(1-2): 153-166.
2. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001; 385(1): 28-40.
3. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophy 2001; 391: 160-164.
4. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmologica Scandinavica 2006; 84(1): 4-15.
5. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201.
6. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 2002; 109(10): 1780-1787.
7. Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 2001; 42(2): 439-446.
8. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the quantification of macular pigment density: First results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 2002; 240(8): 666-671.
9. Jahn C, Wustemeyer H, Brinkmann C, Trautmann S, Mossner A, Wolf S. Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol 2005; 243(3): 222-227.
10. LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R. Macular pigment density and age-related maculopathy in the carotenoids in age-related eye disease study. An ancillary study of the women's health initiative. Ophthalmology 2008; 115(5): 876-883; e871.
11. Berendschot TT, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002; 43(6): 1928-1932.
12. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: A case-control study. Invest Ophthalmol Vis Sci 2001; 42(1): 235-240.
13. Ciulla TA, Curran-Celantano J, Cooper DA, Hammond Jr. BR, Danis RP, Pratt LMet al. Macular pigment optical density in a midwestern sample. Ophthalmology 2001; 108(4): 730-737.
14. Hammond Jr. BR, Caruso-Avery M. Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 2000; 41(6): 1492-1497.
15. Hammond Jr. BR, Curran-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR et al. Sex differences in macular pigment optical density: Relation to plasma carotenoid concentrations and dietary patterns. Vision Res 1996; 36(13): 2001-2012.
16. Hammond Jr. BR, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: Implications for agerelated macular degeneration. Vision Res 1996; 36(18): 3003-3009.
17. Ciulla TA, Hammond Jr. BR. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 2004; 138(4): 582-587.
18. Curran-Celentano J, Hammond Jr. BR, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 2001; 74(6): 796-802.
19. Nolan J, O'Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A et al. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 2004; 45(11): 3940-3950.
20. Hammond Jr. BR, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997; 38(9): 1795-1801.
21. Liew SH, Gilbert CE, Spector TD, Mellerio J, Marshall J, van Kuijk FJ et al. Heritability of macular pigment: A twin study. Invest Ophthalmol Vis Sci 2005; 46(12): 4430-4436.
22. Hammond Jr. BR, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 1997; 14(6): 1187-1196.
23. Sharifzadeh M, Zhao DY, Bernstein PS, Gellermann W. Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis 2008; 25(4): 947-957.
24. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Invest Ophthalmol Vis Sci 1988; 29(6): 843-849.
25. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997; 64(2): 211-218.
26. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 1984; 25(6): 674-685.
27. Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2003; 241(12): 1006-1012.
28. Berendschot TT, van Norren D. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci 2006; 47(2): 709-714.
29. Nolan JM, Stringham JM, Beatty S, Snodderly DM. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 2008; 49(5): 2134-2142.
30. Kirby ML, Galea M, Loane E, Stack J, Beatty S, Nolan JM. Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci 2009; 50(3): 1383-1391.
31. Hogg RE, Dimitrov PN, Dirani M, Varsamidis M, Chamberlain MD, Baird PN et al. Gene-environment interactions and aging visual function: A classical twin study. Ophthalmology 2009; 116(2): 263-269.
32. Chamberlain MD, Guymer RH, Dirani M, Hopper JL, Baird PN. Heritability of macular thickness determined by optical coherence tomography. Invest Ophthalmol Vis Sci 2006; 47(1): 336-340.
33. Martin NG, Martin PG. The inheritance of scholastric abilities in a sample of twins. I. Ascertainments of the sample and diagnosis of zygosity. Ann Hum Genet 1975; 39(2): 213-218.
34. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: Comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 2006; 244(12): 1565-1574.
35. Stockman A, Sharpe LT, Fach C. The spectral sensitivity of the human short-wavelength sensitive cones derived from thresholds and color matches. Vis Res 1999; 39(17): 2901-2927.
36. Hewitt AW, Poulsen JP, Alward WL, Bennett SL, Budde WM, Cooper RL et al. Heritable features of the optic disc: A novel twin method for determining genetic significance. Invest Ophthalmol Vis Sci 2007; 48(6): 2469-2475.
37. Teikari JM, Airaksinen JP. Twin study on cup/disc ratio of the optic nerve head. Br J Ophthalmol 1992; 76(4): 218-220.
38. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 2004; 279(47): 49447-49454.
39. Bhosale P, Li B, Sharifzadeh M, Gellermann W, Frederick JM, Tsuchida K et al. Purification and partial characterization of a lutein-binding protein from human retina. Biochemistry 2009; 48(22): 4798-4807.
40. Dietzel M, Zeimer M, Heimes B, Pauleikhoff D, Hense HW. The ringlike structure of macular pigment in age-related maculopathy: Results from the muenster aging and retina study (Mars). Invest Ophthalmol Vis Sci 2011; 52(11): 8016-8024.
41. Loane E, Nolan JM, O'Donovan O, Bhosale P, Bernstein PS, Beatty S. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol 2008; 53(1): 68-81.
42. Bone RA, Landrum JT. Distribution of macular pigment components, zeaxanthin and lutein, in human retina. Methods Enzymol 1992; 213: 360-366.
43. Wenzel AJ, Sheehan JP, Gerweck C, Stringham JM, Fuld K, Curran-Celentano J. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. Ophthalmic Physiol Opt 2007; 27(4): 329-335.
44. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. Macular pigment and age related degeneration. Br J Ophthalmol 1999; 83(7): 867-877.
45. Berendschot TT, van Norren D. On the age dependency of the macular pigment optical density. Exp Eye Res 2005; 81(5): 602-609.
46. Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GE, Fitzke FW et al. Macular pigment density and distribution: Comparison of fundus autofluorescence with minimum motion photometry. Vis Res 2003; 43(16): 1765-1775.
47. Robson AG, Harding G, van Kuijk FJ, Pauleikhoff D, Holder GE, Bird AC et al. Comparison of fundus autofluorescence and minimum-motion measurements of macular pigment distribution profiles derived from identical retinal areas. Perception 2005; 34(8): 1029-1034.
48. Foster DH, Bischof WF. Bootstrap variance estimators for the parameters of small-sample sensory-performance functions. Biol Cybern 1987; 57(4-5): 341-347.
49. Maloney LT. Confidence intervals for the parameters of psychometric functions. Percept Psychophys 1990; 47(2): 127-134.
50. Taylor HR, West SK. A simple system for the clinical grading of lens opacities. Yan Ke Xue Bao 1988; 4(1): 14-18.
51. Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci 2011; 52(2): 927-932.
52. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102(20): 7227-7232.
53. McKay GJ, Silvestri G, Patterson CC, Hogg RE, Chakravarthy U, Hughes AE. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50(2): 533-539.
54. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 2006; 38(10): 1173-1177.